23.51

0.73% 0.17

After Hours: 23.51

Tyra Biosciences Inc (TYRA)

Overview News Price History Option Chain Financials Discussions Forecast

Tyra Biosciences Inc stock is traded at $23.51, with a volume of 190.96K. It is up +0.73% in the last 24 hours and up +3.30% over the past month. Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Previous Close:

$23.34

Open:

$23.35

24h Volume:

190.96K

Relative Volume:

1.14

Market Cap:

$1.24B

Revenue:

Net Income/Loss:

$-69.13M

P/E Ratio:

-19.59

EPS:

-1.2

Net Cash Flow:

$-50.91M

1W Performance:

-0.55%

1M Performance:

+3.30%

6M Performance:

+43.35%

1Y Performance:

+70.73%

1-Day Range:

$22.89

$24.05

1-Week Range:

$22.85

$24.20

52-Week Range:

$10.38

$25.14

Tyra Biosciences Inc Stock (TYRA) Company Profile

Name

Tyra Biosciences Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(619) 728-4760

Address

2656 STATE STREET, CARLSBAD

Employee

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

TYRA's Discussions on Twitter

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-23	Initiated	Wedbush	Outperform
Feb-03-23	Initiated	Oppenheimer	Outperform
Jun-23-22	Initiated	H.C. Wainwright	Buy
Mar-08-22	Upgrade	Jefferies	Hold → Buy
Nov-08-21	Downgrade	Jefferies	Buy → Hold
Oct-11-21	Initiated	BofA Securities	Buy
Oct-11-21	Initiated	Cowen	Outperform
Oct-11-21	Initiated	Jefferies	Buy

View All

Tyra Biosciences Inc Stock (TYRA) Latest News

07:31 AM

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Perceptive Advisors LLC - MarketBeat

07:31 AM

Sep 28, 2024

American Century Companies Inc. Buys 145,346 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Sep 28, 2024

Sep 27, 2024

Ensign Peak Advisors Inc Invests $3.05 Million in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Sep 27, 2024

Sep 25, 2024

Tyra Biosciences CEO sells over $283k in company stock By Investing.com - Investing.com South Africa

Sep 25, 2024

Tyra Biosciences CEO sells over $283k in company stock - Investing.com

Sep 25, 2024

Tyra Biosciences CEO sells over $283k in company stock By Investing.com - Investing.com UK

Sep 25, 2024

Sep 24, 2024

Ally Bridge Group NY LLC Acquires New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Sep 24, 2024

Sep 22, 2024

(TYRA) Long Term Investment Analysis - Stock Traders Daily

Sep 22, 2024

Sep 21, 2024

Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Todd Harris Sells 5,698 Shares - MarketBeat

Sep 21, 2024

Sep 20, 2024

Tyra Biosciences CEO sells over $394k in company stock By Investing.com - Investing.com South Africa

Sep 20, 2024

Tyra Biosciences CEO sells over $394k in company stock - Investing.com India

Sep 20, 2024

Tyra Biosciences CEO sells over $394k in company stock By Investing.com - Investing.com Canada

Sep 20, 2024

Tyra Biosciences CEO sells over $394k in company stock - Investing.com

Sep 20, 2024

Tyra Biosciences (NASDAQ:TYRA) Price Target Raised to $33.00 - MarketBeat

Sep 20, 2024

Tyra Biosciences (NASDAQ:TYRA) Sets New 52-Week High After Analyst Upgrade - MarketBeat

Sep 20, 2024

Sep 19, 2024

Tyra Biosciences stock soars to 52-week high of $24.28 By Investing.com - Investing.com Canada

Sep 19, 2024

Sep 17, 2024

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - Citizentribune

Sep 11, 2024

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5.7% - MarketBeat

Sep 11, 2024

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - Kilgore News Herald

Sep 11, 2024

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer - Citizentribune

Sep 11, 2024

Sep 10, 2024

Tyra Biosciences names Doug Warner as new Chief Medical Officer - Investing.com

Sep 10, 2024

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer - PR Newswire

Sep 10, 2024

Sep 09, 2024

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet - Yahoo Finance

Sep 09, 2024

Sep 04, 2024

Tyra Biosciences (NASDAQ:TYRA) Trading 3.2% Higher - MarketBeat

Sep 04, 2024

Sep 02, 2024